Premium
SALAZOPYRIN IN THE TREATMENT OF SCLERODERMA
Author(s) -
Barnett A. J.,
Marks R.
Publication year - 1975
Publication title -
australasian journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.67
H-Index - 53
eISSN - 1440-0960
pISSN - 0004-8380
DOI - 10.1111/j.1440-0960.1975.tb00557.x
Subject(s) - medicine , scleroderma (fungus) , dermatology , localized scleroderma , surgery , pathology , lichen sclerosus , inoculation
S ummary Salazopyrin in a dose beginning at 1 g per day and increased to 2 to 4–5g per day, was used for periods of six to 13 months in the treatment of four men with Type 2 scleroderma. One patient claimed symptomatic improvement and a skin stretch test indicated possible decreased skin stiffness. The other patients were not helped. Tests in the patients generally did not show any improvement. Salazopyrin treatment may possibly help occasional patients with scleroderma, but is of limited value.